Renasant Bank Zoetis Inc. Transaction History

Renasant Bank

$138 Million
Q1 2024

A detailed history of Renasant Bank transactions in Zoetis Inc. stock. As of the latest transaction made, Renasant Bank holds 1,325 shares of ZTS stock, worth $231,822. This represents 0.16% of its overall portfolio holdings.

Number of Shares

1,325

Previous 1,344 1.41%

Holding current value

$231,822

Previous $265,000 15.47%

% of portfolio

0.16%

Previous 0.21%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$165.67 - $199.94 $3,147 - $3,798	-19 Reduced 1.41%	1,325 $224,000
Q4 2023 Feb 12, 2024	SELL	$151.44 - $200.09 $7,117 - $9,404	-47 Reduced 3.38%	1,344 $265,000
Q3 2023 Nov 01, 2023	SELL	$167.14 - $192.77 $6,518 - $7,518	-39 Reduced 2.73%	1,391 $242,000
Q2 2023 Aug 01, 2023	SELL	$160.94 - $186.23 $85,781 - $99,260	-533 Reduced 27.15%	1,430 $246,000
Q1 2023 May 05, 2023	SELL	$145.48 - $175.02 $35,788 - $43,054	-246 Reduced 11.14%	1,963 $326,000

Q4 2022 Feb 09, 2023	SELL	$131.14 - $157.47 $19,802 - $23,777	-151 Reduced 6.4%	2,209 $323,000
Q3 2022 Nov 03, 2022	SELL	$148.29 - $182.55 $14,680 - $18,072	-99 Reduced 4.03%	2,360 $350,000
Q2 2022 Aug 03, 2022	SELL	$155.97 - $200.09 $73,773 - $94,642	-473 Reduced 16.13%	2,459 $423,000
Q1 2022 May 12, 2022	BUY	$181.39 - $234.03 $37,910 - $48,912	209 Added 7.68%	2,932 $553,000
Q4 2021 Feb 11, 2022	BUY	$193.69 - $247.03 $182,455 - $232,702	942 Added 52.89%	2,723 $664,000
Q3 2021 Oct 12, 2021	SELL	$189.29 - $209.69 $32,936 - $36,486	-174 Reduced 8.9%	1,781 $346,000
Q2 2021 Jul 19, 2021	BUY	$155.9 - $187.99 $57,527 - $69,368	369 Added 23.27%	1,955 $365,000
Q1 2021 May 17, 2021	BUY	$144.0 - $169.39 $5,040 - $5,928	35 Added 2.26%	1,586 $250,000
Q4 2020 Feb 12, 2021	BUY	$157.07 - $174.35 $243,615 - $270,416	1,551 New	1,551 $256,000

Others Institutions Holding ZTS

# of Institutions

1,860

Shares Held

416M

Call Options Held

1.13M

Put Options Held

1.81M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $81.9B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renasant Bank, based on Form 13F filings with the SEC.

News

Stay updated on Renasant Bank with notifications on news.

Account